Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nova Leap HealthNVLPF -4.76%49 EV-to-FCF is 15.51 as of Aug. 08, 2026, which is 28% above its 10-year median of 12.14. GuruFocus rates NVLPF with a GF Score™ of 49/100 and a GF Value™ of $0.23 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 405 Healthcare Providers & Services companies, Nova Leap Health ranks better than 53.33% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Nova Leap Health's Enterprise Value is $27.23 Mil.
Nova Leap Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $1.76 Mil. Therefore, Nova Leap Health's EV-to-FCF for today is 15.51.
The historical rank and industry rank for Nova Leap Health's EV-to-FCF or its related term are showing as below:
NVLPF'
s EV-to-FCF Range Over the Past 10 Years
Min: -539.65 Med: 12.14 Max: 104.62
Current: 15.51
During the past 10 years, the highest EV-to-FCF of Nova Leap Health was 104.62. The lowest was -539.65. And the median was 12.14.
NVLPF's EV-to-FCF is ranked better than 53.33% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 18.42
vs NVLPF: 15.51
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Nova Leap Health (OTCPK:NVLPF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Nova Leap Health's PE Ratio (TTM) for today is calculated as:
Nova Leap Health's share price for today is $0.29.
Nova Leap Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.003.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Nova Leap Health EV-to-FCF Related Terms
Nova Leap Health EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Nova Leap Health's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Nova Leap Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nova Leap Health EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Nova Leap Health's EV-to-FCF falls into.
Nova Leap Health's current Enterprise Value is $27.23 Mil.
Nova Leap Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.76 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nova Leap Health (NVLPF) has a EV-to-FCF of 15.51 as of Aug. 08, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Nova Leap Health and its competitors. This is 28% above median its historical median of 12.14. According to the industry distribution chart, Nova Leap Health ranks #189 out of 405 companies in the Healthcare Providers & Services industry, placing it in the top 46.7%.
Is Nova Leap Health's EV-to-FCF too high?
Nova Leap Health's current EV-to-FCF of 15.51 is 28% above median its 10-year median of 12.14. The Healthcare Providers & Services industry median EV-to-FCF is 18.42. Nova Leap Health's value of 15.51 is 15.8% below this industry median. Based on the distribution chart, Nova Leap Health ranks #189 out of 405 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nova Leap Health has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nova Leap Health's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nova Leap Health ranks #189 out of 405 companies for EV-to-FCF. This puts Nova Leap Health in the upper half of its industry. The industry median EV-to-FCF is 18.42. Nova Leap Health's value of 15.51 is 15.8% below this benchmark. While the company's 10-year median is 12.14 vs. the industry median of 18.42, Nova Leap Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.42, based on 405 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nova Leap Health's current EV-to-FCF of 15.51 is 15.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Nova Leap Health and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nova Leap Health's current EV-to-FCF is 15.51, which is 28% above median its own 10-year median of 12.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Leap Health stock overvalued right now?
Based on GuruFocus' analysis, Nova Leap Health (NVLPF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.23, compared to a current price of $0.29 — trading 26.1% above its estimated fair value. The current EV-to-FCF is 15.51, which is 28% above median its 10-year median of 12.14 and 15.8% below the Healthcare Providers & Services industry median of 18.42. Nova Leap Health's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Nova Leap Health (NVLPF), the current EV-to-FCF is 15.51 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nova Leap Health (NVLPF) Overvalued in 2026?
Based on GuruFocus' analysis, Nova Leap Health stock appears to be overvalued.
The current stock price of $0.29 is trading 26.1% above its estimated GF Value™ of $0.23.
GuruFocus considers Nova Leap Health to be Modestly Overvalued.
Key valuation signals for NVLPF:
EV-to-FCF: 15.51 (28% above median its 10-year median of 12.14)
GF Value™: $0.23 vs. price of $0.29 (26.1% above fair value)
Industry Position: 15.8% below the Healthcare Providers & Services median (#189 of 405)
No single metric tells the full story. See the NVLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of home and home health care services to clients..The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offerings include meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S. operations. The company derives a majority of its revenue from the United States.
49GF Score
Get the complete analysis for NVLPF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NVLPF has been successfully added to your 
